Therapeutic applications of PARP inhibitors: anticancer therapy and beyond

NJ Curtin, C Szabo - Molecular aspects of medicine, 2013 - Elsevier
The aim of this article is to describe the current and potential clinical translation of
pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …

Poly (ADP-ribose) polymerase (PARP) and PARP inhibitors: mechanisms of action and role in cardiovascular disorders

RJ Henning, M Bourgeois, RD Harbison - Cardiovascular toxicology, 2018 - Springer
Poly (ADP-ribosyl) ation is an immediate cellular repair response to DNA damage and is
catalyzed primarily by poly (ADP-ribose) polymerase-1 (PARP1), which is the most …

Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease

P Pacher, C Szabo - The American journal of pathology, 2008 - Elsevier
Throughout the last 2 decades, experimental evidence from in vitro studies and preclinical
models of disease has demonstrated that reactive oxygen and nitrogen species, including …

Role of poly (ADP‐ribose) polymerase 1 (PARP‐1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

P Pacher, C Szabó - Cardiovascular drug reviews, 2007 - Wiley Online Library
Accumulating evidence suggests that the reactive oxygen and nitrogen species are
generated in cardiomyocytes and endothelial cells during myocardial ischemia/reperfusion …

[HTML][HTML] DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation

D Zhang, X Hu, J Li, J Liu, L Baks-te Bulte… - Nature …, 2019 - nature.com
Atrial fibrillation (AF) is the most common clinical tachyarrhythmia with a strong tendency to
progress in time. AF progression is driven by derailment of protein homeostasis, which …

[HTML][HTML] Signaling mechanism of poly (ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases

X Ba, NJ Garg - The American journal of pathology, 2011 - Elsevier
Poly (ADP-ribosyl) ation, attaching the ADP-ribose polymer chain to the receptor protein, is a
unique posttranslational modification. Poly (ADP-ribose) polymerase-1 (PARP-1) is a well …

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases

A Peralta-Leal, JM Rodríguez-Vargas… - Free Radical Biology …, 2009 - Elsevier
Poly (ADP-ribose) polymerases (PARPs) are defined as cell signaling enzymes that catalyze
the transfer of ADP-ribose units from NAD+ to a number of acceptor proteins. PARP-1, the …

[HTML][HTML] Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes

SM Son - Diabetes & metabolism journal, 2012 - synapse.koreamed.org
Macrovascular and microvascular diseases are currently the principal causes of morbidity
and mortality in subjects with diabetes. Disorders of the physiological signaling functions of …

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

C Szabo - British journal of pharmacology, 2009 - Wiley Online Library
Here we overview the role of reactive nitrogen species (nitrosative stress) and associated
pathways in the pathogenesis of diabetic vascular complications. Increased extracellular …

[HTML][HTML] PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription

C Wang, W Xu, Y Zhang, F Zhang, K Huang - Cell Death & Disease, 2018 - nature.com
Autophagy is a key regulatory process in maintaining cellular homoeostasis via lysosome
degradation. Growing evidence reveals that poly (ADP-ribose) polymerase-1 (PARP1) is …